Will OPTR beat
the market?
the market?
Optimer Pharmaceuticals, Inc.
NASDAQ: OPTR
14.70
-0.27
(-1.80%)
| Today's Open | $14.94 |
|---|---|
| Previous Close | $14.97 |
| Daily Range | $14.61 - $14.95 |
| 52-Week Range | $8.64 - $16.80 |
| Market Cap | $716.2M |
| P/E Ratio | -12.48 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 983,474 |
| Average Daily Volume | 1,105,260 |
| Current FY EPS | -$2.16 |
How do you think OPTR
will perform against the market?
Top OPTR Bull/Bear Pitches
News & Commentary
Is AstraZeneca Gearing Up for a Shopping Spree?
With the company's pipeline in turmoil, AstraZeneca looks into the acquisition game.Optimer Pharmaceuticals Misses on the Top and Bottom Lines
Just the facts, Fool.Why Optimer Pharmaceuticals Shares Sank
Dificid delivers a deficit with regard to Wall Street's expectations.It's Showtime for Optimer Pharmaceuticals
Checking expectations
An FDA approval, the possibility of a small-cap biotech buyout, and updated clinical info from two heavy hitters headline this week's news.
3 Humongous Health-Care Stocks This Week
These health care stocks made big gains to open the new month.Is This Really Big Pharma's Next Acquisition?
Where did all this buyout interest come from?Optimer Pharmaceuticals Shares Soar... for the Right Price, That Is!
A curious quartet of potential bidders sends Optimer's share price soaring to the heavens, but is it really worth the risk?Sector
Healthcare
Industry
Drugs
Optimer Pharmaceuticals, Inc. (OPTR) Description
A biopharmaceutical company focused on discovering, developing and commercializing innovative anti-infective products. Website: http://www.optimerpharma.com/
